Home > Insider Trading > Filing (0001140361-15-018423)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1425205	Lion Biotechnologies Inc.	LBIO	Biological Products, (No Disgnostic Substances) (2836)	753254381

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1471149	Ayer Capital Management, Lp	616 Corporate Way, Suite 2-4931 Valley Cottage NY 10989	No	No	Yes	No
1519940	Acm Capital Partners, Llc	616 Corporate Way, Suite 2-4931 Valley Cottage NY 10989	No	No	Yes	No
1519942	Ayer Capital Partners, Llc	616 Corporate Way, Suite 2-4931 Valley Cottage NY 10989	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-05-01	2,780,682	$9.62	2,823,333	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote

Footnotes

These securities are held by investment funds and a managed account, the investment advisor of which is Ayer Capital Management, LP (the "Advisor"), ACM Capital Partners, LLC ("ACM")is the General Partner of the Advisor, Ayer Capital Partners, LLC (the "GP") is the General Partner of the investment funds. Mr. Venkatesan is the managing member of ACM and the General Partner of the GP.
Each of the Advisor, ACM, the GP, and Mr. Venkatesan disclaims beneficial ownership of these securities except to the extent of its or his pecuniary interest thereof, and the filing of this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
The sale of securities were sold in an underwritten secondary offering of 4,750,000 shares of Lion's common stock at a price to the public of $10.00 per share with a 0.375 gross spread to the underwriters. All shares were offered by the selling stockholders, including certain members of Board of Directors of the Company and certain of their affiliates. Lion Biotechnologies will not sell any shares or receive any proceeds from the offering.